New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
07:14 EDTMYGNNCCN updates guidelines for hereditary colon cancer testing
Myriad Genetics is pleased to note that the National Comprehensive Cancer Network, or NCCN, has revised its medical guidelines to expand Lynch syndrome screening. Lynch syndrome is the most common cause of hereditary colon cancer in adults. Myriad believes the new guidelines will dramatically expand the number of patients eligible for hereditary colon cancer testing, especially among at-risk asymptomatic patients for whom screening has historically been limited based upon prior guidelines and a lack of insurance reimbursement. Some of the key aspects of the new guidelines include: A recommendation that all patients who meet a five percent or greater risk threshold for Lynch syndrome are appropriate for testing; a recommendation against sequential testing for the five Lynch syndrome genes in lieu of panel testing; an acknowledgement that patients with cancer can proceed directly to sequencing tests without a complicated tissue screening algorithm.
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use